Richard J. Radek

Pharmacological Properties of ABT-239 [4-(2-{2-[(2 R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological Characterization and Broad Preclinical Efficacy in Cognition and Schizophrenia of a Potent and Selective Histamine H3 Receptor Antagonist

Gerard B. Fox, Timothy A. Esbenshade, Jia Bao Pan et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 261 citations

Medicine, Neuroscience, Pharmacology +13

Broad-Spectrum Efficacy across Cognitive Domains by α7 Nicotinic Acetylcholine Receptor Agonism Correlates with Activation of ERK1/2 and CREB Phosphorylation Pathways

Robert S. Bitner, William H. Bunnelle, David J. Anderson et al. · Journal of Neuroscience · 2007 · 185 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.

Michael Decker, J D Brioni, J P Sullivan et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 180 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Two Novel and Selective Nonimidazole H3 Receptor Antagonists A-304121 and A-317920: II. In Vivo Behavioral and Neurophysiological Characterization

Gerard B. Fox, Jia Bao Pan, Richard J. Radek et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 101 citations

Medicine, Neuroscience, Pharmacology +9

ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: A Novel, Orally Effective Antinociceptive Agent Acting via Neuronal Nicotinic Acetylcholine Receptors: II. In Vivo Characterization

Anthony W. Bannon, Michael Decker, Peter Curzon et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 77 citations

Medicine, Neuroscience, Pharmacology +17